Product Description
| Cat Number | CP-020 |
|---|---|
| Category | Peptide |
| Pack Size | 1 mg |
| Description | Cell-penetrating dimer of the protein transduction domain (47-58) of HIV-tat |
| Modification | None |
| Purity | >95% by hplc |
| Biomarker Target | Antivirals |
| Sequence Three Letter Code | H-Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Gly-Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Gly-OH |
| Molecular Formula | C132H240N66O29 |
| Sl Sequence | YGRKKRRQRRRGYGRKKRRQRRRG |
| Solubility | Soluble in water |
| Appearance | Freeze dried solid |
| Storage | Store dry, frozen and in the dark |
| References |
Lu et al(2011) HIV-1 Tat-induced microgliosis and synaptic damage via interactions between peripheral and central myeloid cells. PLoS One 6(9) e23915 PMID: 21912650Hargus and Thayer (2013) Human immunodeficiency virus-1 Tat protein increases the number of inhibitory synapses between hippocampal neurons in culture. J Neurosci. 33(45) 17908 PMID: 24198379Zou et al (2017) Progress in Research and Application of HIV-1 TAT-Derived Cell-Penetrating Peptide. J Membr Biol. 250(2) 115 PMID: 27933338 Related areasAll cell penetrating peptides > |
| Note | The product is for research use only |
Share Item: